Pub Date : 2025-09-23eCollection Date: 2025-08-01DOI: 10.1093/ehjimp/qyaf116
G Di Salvo, J Sabatino, S V Babu-Narayan, A Arvanitaki, B Bonello, A Van De Bruaene, M Cantinotti, L Dos Subira, F Raimondi, T Bharucha, R Enache, G Greil, H Latus, M Bhat, E Valsangiacomo, B Cosyns, S E Petersen, V Delgado, H Grotenhuis, M Brida, Jolien W Roos-Hesselink
The congenital heart disease (CHD) population has seen substantial growth due to advancements in paediatric cardiac care, cardiothoracic surgery, anaesthesia, and intensive care. Although improved surgical interventions have enhanced survival rates for even the most severe defects, such as hypoplastic left heart syndrome, most CHD patients remain palliated rather than cured, requiring lifelong expert care. With increasing survival, new challenges emerge in managing the ageing CHD population, particularly regarding changing medical, psychosocial needs, and the evolving epidemiology of CHD. Imaging plays a pivotal role in CHD care, offering precise anatomical and physiological insights necessary for effective management and risk stratification. The European Association of Cardiovascular Imaging (EACVI) established a shared interest group (SIG) to improve imaging standardization, promote education, and foster research for CHD patients. Multimodality imaging, including echocardiography, cardiovascular magnetic resonance (CMR), and computed tomography (CT), is critical in guiding interventions and improving outcomes. The SIG also addresses gaps in education, research, and global healthcare disparities, ensuring a collaborative and systematic approach to CHD care. Advances in imaging technology, genetic research, and tissue engineering hold promise for further improving the longevity and quality of life for CHD patients in the future.
{"title":"The changing landscape of multimodality imaging in congenital heart disease: white paper.","authors":"G Di Salvo, J Sabatino, S V Babu-Narayan, A Arvanitaki, B Bonello, A Van De Bruaene, M Cantinotti, L Dos Subira, F Raimondi, T Bharucha, R Enache, G Greil, H Latus, M Bhat, E Valsangiacomo, B Cosyns, S E Petersen, V Delgado, H Grotenhuis, M Brida, Jolien W Roos-Hesselink","doi":"10.1093/ehjimp/qyaf116","DOIUrl":"10.1093/ehjimp/qyaf116","url":null,"abstract":"<p><p>The congenital heart disease (CHD) population has seen substantial growth due to advancements in paediatric cardiac care, cardiothoracic surgery, anaesthesia, and intensive care. Although improved surgical interventions have enhanced survival rates for even the most severe defects, such as hypoplastic left heart syndrome, most CHD patients remain palliated rather than cured, requiring lifelong expert care. With increasing survival, new challenges emerge in managing the ageing CHD population, particularly regarding changing medical, psychosocial needs, and the evolving epidemiology of CHD. Imaging plays a pivotal role in CHD care, offering precise anatomical and physiological insights necessary for effective management and risk stratification. The European Association of Cardiovascular Imaging (EACVI) established a shared interest group (SIG) to improve imaging standardization, promote education, and foster research for CHD patients. Multimodality imaging, including echocardiography, cardiovascular magnetic resonance (CMR), and computed tomography (CT), is critical in guiding interventions and improving outcomes. The SIG also addresses gaps in education, research, and global healthcare disparities, ensuring a collaborative and systematic approach to CHD care. Advances in imaging technology, genetic research, and tissue engineering hold promise for further improving the longevity and quality of life for CHD patients in the future.</p>","PeriodicalId":94317,"journal":{"name":"European heart journal. Imaging methods and practice","volume":"3 3","pages":"qyaf116"},"PeriodicalIF":0.0,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12527343/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145310583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-12eCollection Date: 2025-07-01DOI: 10.1093/ehjimp/qyaf115
Katarina Steding-Ehrenborg, Anders Nelsson, Henrik Engblom, Ellen Ostenfeld, Per M Arvidsson, Martin Magnusson, J Gustav Smith, Håkan Arheden
Aims: Peak oxygen uptake (VO2peak) is closely related to total heart volume (THV) in healthy individuals. This study aimed to investigate (i) the association between VO2peak and THV in subjects with sub-clinical diastolic dysfunction, athletes, healthy controls, and patients with established heart failure with and without preserved ejection fraction (HFpEF and HFrEF), and (ii) whether VO2peak/THV-index can distinguish between subjects with sub-clinical diastolic dysfunction, HFpEF, HFrEF, and healthy controls.
Methods and results: Seventy participants were included: 15 with sub-clinical diastolic dysfunction (defined as showing only 1-2 echocardiographic signs of diastolic dysfunction, not meeting clinical diagnostic criteria), 10 athletes, 15 healthy controls, and 30 heart failure patients (15 HFpEF and 15 HFrEF). VO2peak was assessed by cardiopulmonary exercise testing and THV by cardiovascular magnetic resonance imaging. In sub-clinical diastolic dysfunction, THV was a weak determinant of VO2peak (R2 = 0.41, P = 0.01), and even weaker in heart failure (R2 = 0.16, P = 0.03). However, THV strongly predicted VO2peak in athletes and controls combined (R2 = 0.87, P < 0.0001). VO2peak/THV did not distinguish healthy controls from sub-clinical diastolic dysfunction but could reliably discriminate between healthy controls and patients with heart failure.
Conclusion: Subjects with sub-clinical diastolic dysfunction may have an altered relationship between VO2peak and THV, approaching that of patients with established heart failure. Thus, this proof-of-concept study indicates that sub-clinical diastolic dysfunction constitutes a group of patients that may be of interest to follow over time to prevent continued deterioration of cardiac function. Furthermore, the VO2peak/THV ratio can be used to distinguish between healthy controls and overt heart failure.
目的:健康个体的最大摄氧量(VO2peak)与心脏总容积(THV)密切相关。本研究旨在探讨(i)亚临床舒张功能不全受试者、运动员、健康对照、有和没有保留射血分数(HFpEF和HFrEF)的心力衰竭患者的VO2peak和THV之间的关系,以及(ii) VO2peak/THV指数是否可以区分亚临床舒张功能不全受试者、HFpEF、HFrEF和健康对照。方法和结果:70名参与者包括:15名亚临床舒张功能不全(定义为仅显示1-2个舒张功能不全的超声心动图征像,不符合临床诊断标准),10名运动员,15名健康对照,30名心力衰竭患者(HFpEF和HFrEF各15名)。心肺运动试验测定vo2峰值,心血管磁共振成像测定THV。在亚临床舒张功能不全时,THV是vo2峰值的弱决定因素(r2 = 0.41, P = 0.01),在心力衰竭时更弱(r2 = 0.16, P = 0.03)。然而,THV能很好地预测运动员和对照组的vo2峰值(r2 = 0.87, P < 0.0001)。VO2peak/THV不能区分健康对照和亚临床舒张功能障碍,但可以可靠地区分健康对照和心力衰竭患者。结论:亚临床舒张功能不全患者的vo2峰值与THV之间的关系可能发生改变,接近心力衰竭患者。因此,这项概念验证研究表明,亚临床舒张功能障碍患者可能有兴趣长期随访,以防止心功能持续恶化。此外,vo2峰值/THV比值可用于区分健康对照和明显的心力衰竭。
{"title":"Low peak oxygen uptake in relation to total heart volume as an early marker of sub-clinical diastolic dysfunction.","authors":"Katarina Steding-Ehrenborg, Anders Nelsson, Henrik Engblom, Ellen Ostenfeld, Per M Arvidsson, Martin Magnusson, J Gustav Smith, Håkan Arheden","doi":"10.1093/ehjimp/qyaf115","DOIUrl":"10.1093/ehjimp/qyaf115","url":null,"abstract":"<p><strong>Aims: </strong>Peak oxygen uptake (VO<sub>2</sub>peak) is closely related to total heart volume (THV) in healthy individuals. This study aimed to investigate (i) the association between VO<sub>2</sub>peak and THV in subjects with sub-clinical diastolic dysfunction, athletes, healthy controls, and patients with established heart failure with and without preserved ejection fraction (HFpEF and HFrEF), and (ii) whether VO<sub>2</sub>peak/THV-index can distinguish between subjects with sub-clinical diastolic dysfunction, HFpEF, HFrEF, and healthy controls.</p><p><strong>Methods and results: </strong>Seventy participants were included: 15 with sub-clinical diastolic dysfunction (defined as showing only 1-2 echocardiographic signs of diastolic dysfunction, not meeting clinical diagnostic criteria), 10 athletes, 15 healthy controls, and 30 heart failure patients (15 HFpEF and 15 HFrEF). VO<sub>2</sub>peak was assessed by cardiopulmonary exercise testing and THV by cardiovascular magnetic resonance imaging. In sub-clinical diastolic dysfunction, THV was a weak determinant of VO<sub>2</sub>peak (<i>R</i> <sup>2</sup> = 0.41, <i>P</i> = 0.01), and even weaker in heart failure (<i>R</i> <sup>2</sup> = 0.16, <i>P</i> = 0.03). However, THV strongly predicted VO<sub>2</sub>peak in athletes and controls combined (<i>R</i> <sup>2</sup> = 0.87, <i>P</i> < 0.0001). VO<sub>2</sub>peak/THV did not distinguish healthy controls from sub-clinical diastolic dysfunction but could reliably discriminate between healthy controls and patients with heart failure.</p><p><strong>Conclusion: </strong>Subjects with sub-clinical diastolic dysfunction may have an altered relationship between VO<sub>2</sub>peak and THV, approaching that of patients with established heart failure. Thus, this proof-of-concept study indicates that sub-clinical diastolic dysfunction constitutes a group of patients that may be of interest to follow over time to prevent continued deterioration of cardiac function. Furthermore, the VO<sub>2</sub>peak/THV ratio can be used to distinguish between healthy controls and overt heart failure.</p>","PeriodicalId":94317,"journal":{"name":"European heart journal. Imaging methods and practice","volume":"3 2","pages":"qyaf115"},"PeriodicalIF":0.0,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12459250/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145152680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-02eCollection Date: 2025-10-01DOI: 10.1093/ehjimp/qyaf113
Mohamed Kira, Lavinia Gabara, Mohamed Abouelasaad, Hussein Bashar, Ahmed Elserwey, Zoe Nicholas, Campbell Rogers, Sam Wilding, Pamela S Douglas, Mark Hlatky, Nick Curzen
<p><strong>Aims: </strong>The original FORECAST trial was designed to compare a strategy of computed tomography coronary angiography (CTCA) and selective FFR<sub>CT</sub> to standard care in patients attending Rapid Access Chest Pain clinics in UK centres. This is a prespecified analysis of the FORECAST trial to compare outcomes between the patients in the experimental arm (CTCA + selective FFR<sub>CT</sub>) and patients in the reference arm who underwent CTCA alone as their initial test of choice.</p><p><strong>Methods and results: </strong>The FORECAST trial recruited 1400 patients randomized between two strategies: (i) initial test of choice at the discretion of the healthcare provider (standard care arm) or (ii) CTCA ± FFR<sub>CT</sub>. Prior to randomization, clinicians stated their preference for choice of the first test if the patient were to be randomized to standard care. A total of 459 patients (66%) in the standard care pathway were selected for CTCA as the first test of choice. Similarly, 453 (65%) of the patients who were subsequently randomized into the experimental arm were selected for CTCA as initial test prior to that randomization. This comparison is an intention-to-test (ITT) analysis comparing the post-randomization outcomes of the population of patients who were selected for CTCA as the test of first choice prior to randomization (labelled as the CTCA stratum). The following comparisons were made: (i) primary trial outcomes at 9 months including (a) total cardiac costs, (b) use of other tests, (c) clinical events, and (d) time to final management plan; (ii) a comparison between the CTCA stratum groups and the remainder of the standard care arm (i.e. patients randomized to standard care who were selected for an initial test other than CTCA). Of the CTCA stratum patients, there was no significant difference between randomized groups in the median total cardiac costs at 9 months [£594 (IQR 570-1127) in the experimental arm vs. £594 (574-966) in the usual care arm (<i>P</i> = 0.325)]. The number of additional non-invasive tests was significantly lower in the experimental group than in the standard care CTCA patients [43 patients (8.9%) vs. 72 (16%), <i>P</i> = 0.005]. Time to final management plan was also significantly lower in the experimental arm [median 64 days (IQR 48-110) vs. 75 days (55-126), <i>P</i> < 0.001]. There was no significant difference in the rate of adverse cardiac events. Patients randomized to standard care who were not in the CTCA stratum had significantly higher median total cardiac costs when compared with either of the CTCA stratum groups, with median total cardiac costs of £908 (IQR 592-1161) vs. £594 (570-1123) vs. £594 (570-966), respectively (<i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>In this prespecified FORECAST substudy of patients whose clinicians preferred CTCA as the first test prior to randomization, the CTCA ± FFR<sub>CT</sub> strategy, when compared with CTCA alone, was cost-neutr
{"title":"Comparison of computed tomography coronary angiography (CTCA) alone vs. CTCA with selective FFR<sub>CT</sub> in patients presenting with stable chest pain: a FORECAST trial substudy.","authors":"Mohamed Kira, Lavinia Gabara, Mohamed Abouelasaad, Hussein Bashar, Ahmed Elserwey, Zoe Nicholas, Campbell Rogers, Sam Wilding, Pamela S Douglas, Mark Hlatky, Nick Curzen","doi":"10.1093/ehjimp/qyaf113","DOIUrl":"10.1093/ehjimp/qyaf113","url":null,"abstract":"<p><strong>Aims: </strong>The original FORECAST trial was designed to compare a strategy of computed tomography coronary angiography (CTCA) and selective FFR<sub>CT</sub> to standard care in patients attending Rapid Access Chest Pain clinics in UK centres. This is a prespecified analysis of the FORECAST trial to compare outcomes between the patients in the experimental arm (CTCA + selective FFR<sub>CT</sub>) and patients in the reference arm who underwent CTCA alone as their initial test of choice.</p><p><strong>Methods and results: </strong>The FORECAST trial recruited 1400 patients randomized between two strategies: (i) initial test of choice at the discretion of the healthcare provider (standard care arm) or (ii) CTCA ± FFR<sub>CT</sub>. Prior to randomization, clinicians stated their preference for choice of the first test if the patient were to be randomized to standard care. A total of 459 patients (66%) in the standard care pathway were selected for CTCA as the first test of choice. Similarly, 453 (65%) of the patients who were subsequently randomized into the experimental arm were selected for CTCA as initial test prior to that randomization. This comparison is an intention-to-test (ITT) analysis comparing the post-randomization outcomes of the population of patients who were selected for CTCA as the test of first choice prior to randomization (labelled as the CTCA stratum). The following comparisons were made: (i) primary trial outcomes at 9 months including (a) total cardiac costs, (b) use of other tests, (c) clinical events, and (d) time to final management plan; (ii) a comparison between the CTCA stratum groups and the remainder of the standard care arm (i.e. patients randomized to standard care who were selected for an initial test other than CTCA). Of the CTCA stratum patients, there was no significant difference between randomized groups in the median total cardiac costs at 9 months [£594 (IQR 570-1127) in the experimental arm vs. £594 (574-966) in the usual care arm (<i>P</i> = 0.325)]. The number of additional non-invasive tests was significantly lower in the experimental group than in the standard care CTCA patients [43 patients (8.9%) vs. 72 (16%), <i>P</i> = 0.005]. Time to final management plan was also significantly lower in the experimental arm [median 64 days (IQR 48-110) vs. 75 days (55-126), <i>P</i> < 0.001]. There was no significant difference in the rate of adverse cardiac events. Patients randomized to standard care who were not in the CTCA stratum had significantly higher median total cardiac costs when compared with either of the CTCA stratum groups, with median total cardiac costs of £908 (IQR 592-1161) vs. £594 (570-1123) vs. £594 (570-966), respectively (<i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>In this prespecified FORECAST substudy of patients whose clinicians preferred CTCA as the first test prior to randomization, the CTCA ± FFR<sub>CT</sub> strategy, when compared with CTCA alone, was cost-neutr","PeriodicalId":94317,"journal":{"name":"European heart journal. Imaging methods and practice","volume":"3 4","pages":"qyaf113"},"PeriodicalIF":0.0,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12502911/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145254272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aims: Left ventricular (LV) global longitudinal strain (GLS) is a sensitive marker for detection of subclinical LV systolic dysfunction, but variability in acquisition and analysis may limit its clinical utility. We studied the accuracy, variability, and correlation of LV GLS across different 2D and 3D echocardiographic acquisition methods and post-processing platforms.
Methods and results: In this prospective study, we analyzed 254 consecutive patients (mean age 55 ± 16 years, 60% female) undergoing clinically indicated echo. GLS was measured using multiple 2D acquisition methods (three beats and single beat) and 3D. Analyses were performed using both vendor-specific (EchoPac) and vendor-neutral (TomTec-Arena) software. Correlations and agreement between methods were assessed using Pearson correlation, intraclass correlation coefficients (ICCs), and Bland-Altman analyses.GLS values were highly consistent across the acquisition methods and between software platforms. Mean GLS values were -19.4 ± 3.3 (2D-A), -19.2 ± 3.3 (2D-B), -19.1 ± 3.5 (3P), and -14.8 ± 4.1 (3D). Intra- and interobserver variability for 2D GLS was low (ICC >0.9), indicating excellent reproducibility. However, 3D GLS values were significantly lower than 2D (mean difference -4.3%), with only moderate correlation (r = 0.66), suggesting that 2D and 3D GLS values are not interchangeable.
Conclusion: The LV GLS is a reliable method for assessment of LV function with strong reproducibility across differing acquisition and analysis methods. However, 3D GLS is consistently lower and should not be used interchangeably with 2D measurements. These findings underscore the need for ongoing standardization and caution in comparing GLS values across 2D and 3D methods.
{"title":"Reliability of left ventricular global longitudinal strain across acquisition and analysis techniques: a prospective comparative study.","authors":"FeiFei Gong, Nausheen Akhter, Inga Vaitenas, Bernadette Wodzinski, Nicola Lancki, Leah J Welty, Kameswari Maganti","doi":"10.1093/ehjimp/qyaf101","DOIUrl":"10.1093/ehjimp/qyaf101","url":null,"abstract":"<p><strong>Aims: </strong>Left ventricular (LV) global longitudinal strain (GLS) is a sensitive marker for detection of subclinical LV systolic dysfunction, but variability in acquisition and analysis may limit its clinical utility. We studied the accuracy, variability, and correlation of LV GLS across different 2D and 3D echocardiographic acquisition methods and post-processing platforms.</p><p><strong>Methods and results: </strong>In this prospective study, we analyzed 254 consecutive patients (mean age 55 ± 16 years, 60% female) undergoing clinically indicated echo. GLS was measured using multiple 2D acquisition methods (three beats and single beat) and 3D. Analyses were performed using both vendor-specific (EchoPac) and vendor-neutral (TomTec-Arena) software. Correlations and agreement between methods were assessed using Pearson correlation, intraclass correlation coefficients (ICCs), and Bland-Altman analyses.GLS values were highly consistent across the acquisition methods and between software platforms. Mean GLS values were -19.4 ± 3.3 (2D-A), -19.2 ± 3.3 (2D-B), -19.1 ± 3.5 (3P), and -14.8 ± 4.1 (3D). Intra- and interobserver variability for 2D GLS was low (ICC >0.9), indicating excellent reproducibility. However, 3D GLS values were significantly lower than 2D (mean difference -4.3%), with only moderate correlation (<i>r</i> = 0.66), suggesting that 2D and 3D GLS values are not interchangeable.</p><p><strong>Conclusion: </strong>The LV GLS is a reliable method for assessment of LV function with strong reproducibility across differing acquisition and analysis methods. However, 3D GLS is consistently lower and should not be used interchangeably with 2D measurements. These findings underscore the need for ongoing standardization and caution in comparing GLS values across 2D and 3D methods.</p>","PeriodicalId":94317,"journal":{"name":"European heart journal. Imaging methods and practice","volume":"3 2","pages":"qyaf101"},"PeriodicalIF":0.0,"publicationDate":"2025-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12405870/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145002401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-25eCollection Date: 2025-07-01DOI: 10.1093/ehjimp/qyaf084
Amanda de Vasconcelos Eng, João Afonso Astolfi Martins, Edgar Bezerra Lira Filho, Claudio Henrique Fischer, Claudia Gianini Monaco, Alessandra Joslin Oliveira, Fernando Rodrigues da Camara Oliveira, Marcelo Luiz Campos Vieira, Samira Saady Morhy, Ana Clara Tude Rodrigues
Aims: Transoesophageal echocardiography (TEE) is widely used for cardiac assessment and requires moderate sedation due to its semi-invasive nature, carrying potential risks. Music is a non-pharmacological strategy shown to reduce anxiety in various clinical settings. We prospectively investigated whether music could reduce anxiety and/or sedation dosage in patients undergoing TEE.
Methods and results: Sixty-three patients (>18 years) referred for TEE were randomized into a music group (n = 31) or control group (n = 32). All completed an anxiety questionnaire and had haemodynamic parameters (blood pressure, heart rate, oxygen saturation) assessed prior to transthoracic echocardiography (TTE). Music was played before TTE and continued throughout TEE in the intervention group. Anxiety and haemodynamic measurements were repeated after TTE, before sedation. Groups were compared for baseline characteristics, anxiety levels, haemodynamic changes, and midazolam dosage. There was no difference between the groups regarding age or sex; control group had more comorbidities. Anxiety levels did not differ between groups at baseline or pre-sedation (P > 0.05). A significant reduction over time was observed only in the music group (P = 0.032 vs. P = 0.069), but group-by-time interaction was not significant (P = 0.347). Regarding anxiety level, it decreased in both groups, more markedly in the music group (P < 0.008 vs. P = 0.04). Diastolic blood pressure also decreased after music exposure (P = 0.024). Midazolam dosage did not differ between groups but was inversely correlated with age.
Conclusion: Although music did not reduce sedation requirements, it significantly decreased anxiety levels and blood pressure; music may be a valuable adjunct to sedation in patients undergoing TEE.
目的:经食管超声心动图(TEE)被广泛用于心脏评估,由于其半侵入性,需要适度镇静,存在潜在风险。在各种临床环境中,音乐是一种非药物策略,可以减少焦虑。我们前瞻性地研究了音乐是否可以减少TEE患者的焦虑和/或镇静剂量。方法与结果:63例接受TEE治疗的患者(0 ~ 18岁)随机分为音乐组(n = 31)和对照组(n = 32)。所有人都完成了一份焦虑问卷,并在经胸超声心动图(TTE)之前评估了血流动力学参数(血压、心率、血氧饱和度)。音乐在治疗前播放,并在干预组的整个治疗过程中持续播放。镇静前,在TTE后重复焦虑和血流动力学测量。比较各组的基线特征、焦虑水平、血流动力学变化和咪达唑仑剂量。两组之间在年龄和性别方面没有差异;对照组的合并症较多。两组在基线和镇静前的焦虑水平无显著差异(P < 0.05)。随着时间的推移,仅在音乐组观察到显著降低(P = 0.032 vs. P = 0.069),但组间时间的相互作用不显著(P = 0.347)。在焦虑水平方面,两组均有下降,其中音乐组下降更明显(P < 0.008 vs. P = 0.04)。音乐暴露后舒张压也降低(P = 0.024)。咪达唑仑剂量组间无差异,但与年龄呈负相关。结论:虽然音乐没有减少镇静需求,但它显著降低了焦虑水平和血压;对于接受TEE治疗的患者,音乐可能是一种有价值的镇静辅助手段。
{"title":"Use of music as an adjunct to sedation in patients undergoing transoesophageal echocardiography.","authors":"Amanda de Vasconcelos Eng, João Afonso Astolfi Martins, Edgar Bezerra Lira Filho, Claudio Henrique Fischer, Claudia Gianini Monaco, Alessandra Joslin Oliveira, Fernando Rodrigues da Camara Oliveira, Marcelo Luiz Campos Vieira, Samira Saady Morhy, Ana Clara Tude Rodrigues","doi":"10.1093/ehjimp/qyaf084","DOIUrl":"10.1093/ehjimp/qyaf084","url":null,"abstract":"<p><strong>Aims: </strong>Transoesophageal echocardiography (TEE) is widely used for cardiac assessment and requires moderate sedation due to its semi-invasive nature, carrying potential risks. Music is a non-pharmacological strategy shown to reduce anxiety in various clinical settings. We prospectively investigated whether music could reduce anxiety and/or sedation dosage in patients undergoing TEE.</p><p><strong>Methods and results: </strong>Sixty-three patients (>18 years) referred for TEE were randomized into a music group (<i>n</i> = 31) or control group (<i>n</i> = 32). All completed an anxiety questionnaire and had haemodynamic parameters (blood pressure, heart rate, oxygen saturation) assessed prior to transthoracic echocardiography (TTE). Music was played before TTE and continued throughout TEE in the intervention group. Anxiety and haemodynamic measurements were repeated after TTE, before sedation. Groups were compared for baseline characteristics, anxiety levels, haemodynamic changes, and midazolam dosage. There was no difference between the groups regarding age or sex; control group had more comorbidities. Anxiety levels did not differ between groups at baseline or pre-sedation (<i>P</i> > 0.05). A significant reduction over time was observed only in the music group (<i>P</i> = 0.032 vs. <i>P</i> = 0.069), but group-by-time interaction was not significant (<i>P</i> = 0.347). Regarding anxiety level, it decreased in both groups, more markedly in the music group (<i>P</i> < 0.008 vs. <i>P</i> = 0.04). Diastolic blood pressure also decreased after music exposure (<i>P</i> = 0.024). Midazolam dosage did not differ between groups but was inversely correlated with age.</p><p><strong>Conclusion: </strong>Although music did not reduce sedation requirements, it significantly decreased anxiety levels and blood pressure; music may be a valuable adjunct to sedation in patients undergoing TEE.</p>","PeriodicalId":94317,"journal":{"name":"European heart journal. Imaging methods and practice","volume":"3 2","pages":"qyaf084"},"PeriodicalIF":0.0,"publicationDate":"2025-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12377499/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144984858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-25eCollection Date: 2025-10-01DOI: 10.1093/ehjimp/qyaf110
Sabha Bhatti, Shakeela Naz, Sumyia Gurmani, Wajid Hussain, Uzma Atif, Shazia Ahmed, Kiran Zahra, Haleema Yasmin, Ali Khan, Musa Karim, Abdul Hakeem
Aims: The Prospective Pakistan Registry of Echocardiographic Screening in Asymptomatic Pregnant Women (PRESAP) is a registry designed for the echocardiographic screening of structural heart disease (SHD). It offers a unique opportunity to compare the effectiveness of point-of-care ultrasound (POCUS) vs. routine transthoracic echocardiography (TTE) in this population. This sub-study of the PRESAP registry aimed to compare the detection of SHD in asymptomatic pregnant women using POCUS vs. routine TTE.
Methods and results: Between February 2023 and March 2024, pregnant women without known heart disease were enrolled in the PRESAP registry. Participants underwent a limited echocardiogram, using either POCUS or TTE. The primary outcome was the detection of abnormal findings, including left ventricular systolic dysfunction (LVSD), valvular heart disease (VHD), and congenital heart disease (CHD). Matching cohorts were created using propensity score matching, based on demographic factors, comorbid conditions, and gestational history. Among 18 401 patients, 9681 (52.6%) underwent POCUS. The 1:1 propensity-matched cohort included 4177 patients in each arm. Abnormal echocardiographic findings were detected in 4.4% (185) of the TTE group and 3% (124) of the POCUS group (P < 0.001). VHD (1.3% vs. 1.1%; P = 0.416) and CHD (0.4% vs. 0.6%; P = 0.093) were detected at similar rates by both methods, while LVSD was more frequently identified by TTE compared with POCUS (2.8% vs. 1.5%; P < 0.001).
Conclusion: POCUS may be considered as an alternative to TTE for screening for SHD in asymptomatic pregnant women, particularly in resource-limited settings. TTE was superior for LVSD, and POCUS was equally effective in identifying valvular and congenital heart disease.
目的:巴基斯坦无症状孕妇超声心动图筛查前瞻性登记(PRESAP)是一个为结构性心脏病(SHD)超声心动图筛查设计的登记。它提供了一个独特的机会来比较护理点超声(POCUS)与常规经胸超声心动图(TTE)在这一人群中的有效性。这项preap注册的子研究旨在比较POCUS和常规TTE在无症状孕妇中对SHD的检测。方法和结果:在2023年2月至2024年3月期间,没有已知心脏病的孕妇被纳入PRESAP登记。参与者使用POCUS或TTE进行有限超声心动图检查。主要结局是异常发现的检测,包括左心室收缩功能障碍(LVSD)、瓣瓣性心脏病(VHD)和先天性心脏病(CHD)。根据人口统计学因素、合并症和妊娠史,使用倾向评分匹配创建匹配队列。在18401例患者中,9681例(52.6%)行POCUS。1:1倾向匹配的队列包括每组4177例患者。TTE组185例(4.4%)、POCUS组124例(3%)超声心动图异常(P < 0.001)。两种方法对VHD (1.3% vs. 1.1%, P = 0.416)和CHD (0.4% vs. 0.6%, P = 0.093)的检出率相似,而TTE对LVSD的检出率高于POCUS (2.8% vs. 1.5%, P < 0.001)。结论:POCUS可作为一种替代TTE筛查无症状孕妇SHD的方法,特别是在资源有限的情况下。TTE在诊断LVSD方面优于POCUS,在诊断瓣膜性心脏病和先天性心脏病方面同样有效。
{"title":"Point-of-care ultrasound vs. routine transthoracic echocardiography for screening of cardiovascular disease in pregnant women.","authors":"Sabha Bhatti, Shakeela Naz, Sumyia Gurmani, Wajid Hussain, Uzma Atif, Shazia Ahmed, Kiran Zahra, Haleema Yasmin, Ali Khan, Musa Karim, Abdul Hakeem","doi":"10.1093/ehjimp/qyaf110","DOIUrl":"10.1093/ehjimp/qyaf110","url":null,"abstract":"<p><strong>Aims: </strong>The Prospective Pakistan Registry of Echocardiographic Screening in Asymptomatic Pregnant Women (PRESAP) is a registry designed for the echocardiographic screening of structural heart disease (SHD). It offers a unique opportunity to compare the effectiveness of point-of-care ultrasound (POCUS) vs. routine transthoracic echocardiography (TTE) in this population. This sub-study of the PRESAP registry aimed to compare the detection of SHD in asymptomatic pregnant women using POCUS vs. routine TTE.</p><p><strong>Methods and results: </strong>Between February 2023 and March 2024, pregnant women without known heart disease were enrolled in the PRESAP registry. Participants underwent a limited echocardiogram, using either POCUS or TTE. The primary outcome was the detection of abnormal findings, including left ventricular systolic dysfunction (LVSD), valvular heart disease (VHD), and congenital heart disease (CHD). Matching cohorts were created using propensity score matching, based on demographic factors, comorbid conditions, and gestational history. Among 18 401 patients, 9681 (52.6%) underwent POCUS. The 1:1 propensity-matched cohort included 4177 patients in each arm. Abnormal echocardiographic findings were detected in 4.4% (185) of the TTE group and 3% (124) of the POCUS group (<i>P</i> < 0.001). VHD (1.3% vs. 1.1%; <i>P</i> = 0.416) and CHD (0.4% vs. 0.6%; <i>P</i> = 0.093) were detected at similar rates by both methods, while LVSD was more frequently identified by TTE compared with POCUS (2.8% vs. 1.5%; <i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>POCUS may be considered as an alternative to TTE for screening for SHD in asymptomatic pregnant women, particularly in resource-limited settings. TTE was superior for LVSD, and POCUS was equally effective in identifying valvular and congenital heart disease.</p>","PeriodicalId":94317,"journal":{"name":"European heart journal. Imaging methods and practice","volume":"3 4","pages":"qyaf110"},"PeriodicalIF":0.0,"publicationDate":"2025-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12502912/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145254197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-20eCollection Date: 2025-07-01DOI: 10.1093/ehjimp/qyaf112
David Sulman, Stéphane Manzo-Silberman
The 2019 ESC guidelines redefined stable coronary artery disease as chronic coronary syndrome (CCS), highlighting the dynamic nature of this disease. This condition is characterized by the gradual accumulation of atherosclerotic plaques in the epicardial coronary arteries. CCS can result in myocardial ischaemia due to supply-demand mismatch, often triggered by physical or emotional stress. The clinical course may be abruptly interrupted by plaque rupture or erosion, leading to acute coronary syndromes. Revolutionary advances in non-invasive imaging have transformed the chronic coronary syndrome diagnosis algorithm and management. Coronary computed tomography angiography provides detailed anatomical insights, identifying high-risk plaques with features like low attenuation and positive remodelling, as evidenced by SCOT-HEART, which reported reduced coronary events (HR: 0.59, P = 0.004). Stress echocardiography may detect ischaemia-induced wall motion abnormalities (sensitivity, 85-95%), while cardiovascular magnetic resonance is paramount in functional assessment, offering 81-86% sensitivity/specificity and detecting microvascular dysfunction via perfusion and late gadolinium enhancement. Nuclear imaging (SPECT/PET) enhances ischaemia detection, with PET's myocardial flow reserve improving prognostic accuracy (sensitivity 90%, specificity 88%). AI-driven innovations, such as CT-derived fractional flow reserve, automate plaque quantification and may reduce in the future unnecessary invasive angiographies by 19-25% (P = 0.01), while dynamic CT myocardial perfusion integrates anatomical and hemodynamic data, boosting diagnostic accuracy (87%). These advancements enable precise risk stratification and a personalized multimodal imaging approach, based on pre-test likelihood. It also increases the risk of unsustainable costs for society, repeated radiation exposure throughout a patient's life, and raises the question of actual limited benefits from revascularization in low-risk patients.
2019年ESC指南将稳定型冠状动脉疾病重新定义为慢性冠状动脉综合征(CCS),强调了这种疾病的动态性。这种疾病的特点是在心外膜冠状动脉中逐渐积累动脉粥样硬化斑块。由于供需不匹配,通常由身体或情绪压力引发,CCS可导致心肌缺血。临床过程可能因斑块破裂或糜烂而突然中断,导致急性冠状动脉综合征。非侵入性影像学的革命性进步已经改变了慢性冠状动脉综合征的诊断算法和管理。冠状动脉计算机断层血管造影提供了详细的解剖学信息,识别出具有低衰减和阳性重构等特征的高危斑块,如SCOT-HEART报告的冠状动脉事件减少(HR: 0.59, P = 0.004)。应激超声心动图可以检测缺血引起的壁运动异常(敏感性85-95%),而心血管磁共振在功能评估中至关重要,其敏感性/特异性为81-86%,并通过灌注和晚期钆增强检测微血管功能障碍。核成像(SPECT/PET)增强了缺血检测,PET的心肌血流储备提高了预后准确性(灵敏度90%,特异性88%)。人工智能驱动的创新,如CT衍生的血流储备分数,自动量化斑块,并可能在未来减少19-25%的不必要的侵入性血管造影(P = 0.01),而动态CT心肌灌注整合了解剖学和血流动力学数据,提高了诊断准确性(87%)。这些进步使精确的风险分层和个性化的多模式成像方法成为可能,基于测试前的可能性。它还增加了社会不可持续成本的风险,增加了患者一生中反复暴露于辐射的风险,并提出了低风险患者血运重建的实际效益有限的问题。
{"title":"What role for cardiac imaging in chronic coronary syndromes: review of the literature in light of the latest recommendations.","authors":"David Sulman, Stéphane Manzo-Silberman","doi":"10.1093/ehjimp/qyaf112","DOIUrl":"10.1093/ehjimp/qyaf112","url":null,"abstract":"<p><p>The 2019 ESC guidelines redefined stable coronary artery disease as chronic coronary syndrome (CCS), highlighting the dynamic nature of this disease. This condition is characterized by the gradual accumulation of atherosclerotic plaques in the epicardial coronary arteries. CCS can result in myocardial ischaemia due to supply-demand mismatch, often triggered by physical or emotional stress. The clinical course may be abruptly interrupted by plaque rupture or erosion, leading to acute coronary syndromes. Revolutionary advances in non-invasive imaging have transformed the chronic coronary syndrome diagnosis algorithm and management. Coronary computed tomography angiography provides detailed anatomical insights, identifying high-risk plaques with features like low attenuation and positive remodelling, as evidenced by SCOT-HEART, which reported reduced coronary events (HR: 0.59, <i>P</i> = 0.004). Stress echocardiography may detect ischaemia-induced wall motion abnormalities (sensitivity, 85-95%), while cardiovascular magnetic resonance is paramount in functional assessment, offering 81-86% sensitivity/specificity and detecting microvascular dysfunction via perfusion and late gadolinium enhancement. Nuclear imaging (SPECT/PET) enhances ischaemia detection, with PET's myocardial flow reserve improving prognostic accuracy (sensitivity 90%, specificity 88%). AI-driven innovations, such as CT-derived fractional flow reserve, automate plaque quantification and may reduce in the future unnecessary invasive angiographies by 19-25% (<i>P</i> = 0.01), while dynamic CT myocardial perfusion integrates anatomical and hemodynamic data, boosting diagnostic accuracy (87%). These advancements enable precise risk stratification and a personalized multimodal imaging approach, based on pre-test likelihood. It also increases the risk of unsustainable costs for society, repeated radiation exposure throughout a patient's life, and raises the question of actual limited benefits from revascularization in low-risk patients.</p>","PeriodicalId":94317,"journal":{"name":"European heart journal. Imaging methods and practice","volume":"3 2","pages":"qyaf112"},"PeriodicalIF":0.0,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12448739/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145115840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-20eCollection Date: 2025-07-01DOI: 10.1093/ehjimp/qyaf111
Albert Dayor Piersson, Bismark Ofori-Manteaw, Hanifatu Napari Mumuni, Klenam Dzefi-Tettey
Aims: We assessed the readability level of online patient education materials (PEMs) for cardiac MRI (CMRI) to determine whether they meet the standard health literacy needs as determined by the US National Institutes of Health and the American Medical Association guidelines.
Methods and results: We evaluated the readability of CMRI PEMs from 5 websites using the Flesch-Kincaid Reading Ease (FKRE), Flesch-Kincaid grade level (FKGL), Gunning-Fog Index (GFI), Simple Measure of Gobbledygook index (SMOGI), Coleman-Liau Index (CLI), and Automated Readability Index (ARI). PEMs on the British Heart Foundation (BHF) website yielded the highest mean FKRE score, while the RadiologyInfo.org (RadInfo) website yielded the highest mean score on the CLI compared to all the other websites. Statistical analysis of individual predictors revealed that average words per sentence (P < 0.001) and average syllables per word (P < 0.001) were strong determinants of FKRE for the RadInfo PEMs. In contrast, sentences (P = 0.044), words (P = 0.046), average words per sentence (P = <0.001), and average syllables per word (P = <0.001) were significant predictors of FKRE for the InsideRadiology (InsRad) PEMs. The sensitivity analysis consistently confirmed the robustness and primary influence of average words per sentence and average syllables per word.
Conclusion: The BHF and American Heart Association emphasize accessible CMRI communication, whereas RadInfo, InsRad, and the European Society of Cardiology PEMs may be less suitable for low-health-literacy audiences. Strategies aimed at enhancing the comprehensibility of patient education materials should primarily focus on reducing the average complexity of words and shortening average sentence lengths.
目的:我们评估了用于心脏MRI (CMRI)的在线患者教育材料(PEMs)的可读性水平,以确定它们是否符合美国国立卫生研究院和美国医学协会指南所确定的标准健康素养需求。方法与结果:采用Flesch-Kincaid Reading Ease (FKRE)、Flesch-Kincaid grade level (FKGL)、Gunning-Fog Index (GFI)、Simple Measure of Gobbledygook Index (SMOGI)、Coleman-Liau Index (CLI)和Automated readability Index (ARI)对5个网站的CMRI PEMs进行可读性评价。英国心脏基金会(BHF)网站上的PEMs的FKRE平均得分最高,而RadiologyInfo.org (RadInfo)网站的CLI平均得分最高。个体预测因子的统计分析显示,每句平均单词数(P < 0.001)和每个单词平均音节数(P < 0.001)是RadInfo PEMs的FKRE的重要决定因素。相比之下,句子(P = 0.044)、单词(P = 0.046)、平均每句单词(P = P = P =结论:BHF和美国心脏协会强调可访问的CMRI交流,而RadInfo、InsRad和欧洲心脏病学会的PEMs可能不太适合低健康素养的受众。旨在提高患者教育材料的可理解性的策略应主要侧重于降低单词的平均复杂程度和缩短平均句子长度。
{"title":"Readability of patient education materials on cardiac magnetic resonance imaging.","authors":"Albert Dayor Piersson, Bismark Ofori-Manteaw, Hanifatu Napari Mumuni, Klenam Dzefi-Tettey","doi":"10.1093/ehjimp/qyaf111","DOIUrl":"10.1093/ehjimp/qyaf111","url":null,"abstract":"<p><strong>Aims: </strong>We assessed the readability level of online patient education materials (PEMs) for cardiac MRI (CMRI) to determine whether they meet the standard health literacy needs as determined by the US National Institutes of Health and the American Medical Association guidelines.</p><p><strong>Methods and results: </strong>We evaluated the readability of CMRI PEMs from 5 websites using the Flesch-Kincaid Reading Ease (FKRE), Flesch-Kincaid grade level (FKGL), Gunning-Fog Index (GFI), Simple Measure of Gobbledygook index (SMOGI), Coleman-Liau Index (CLI), and Automated Readability Index (ARI). PEMs on the British Heart Foundation (BHF) website yielded the highest mean FKRE score, while the RadiologyInfo.org (RadInfo) website yielded the highest mean score on the CLI compared to all the other websites. Statistical analysis of individual predictors revealed that average words per sentence (<i>P</i> < 0.001) and average syllables per word (<i>P</i> < 0.001) were strong determinants of FKRE for the RadInfo PEMs. In contrast, sentences (<i>P</i> = 0.044), words (<i>P</i> = 0.046), average words per sentence (<i>P</i> = <0.001), and average syllables per word (<i>P</i> = <0.001) were significant predictors of FKRE for the InsideRadiology (InsRad) PEMs. The sensitivity analysis consistently confirmed the robustness and primary influence of average words per sentence and average syllables per word.</p><p><strong>Conclusion: </strong>The BHF and American Heart Association emphasize accessible CMRI communication, whereas RadInfo, InsRad, and the European Society of Cardiology PEMs may be less suitable for low-health-literacy audiences. Strategies aimed at enhancing the comprehensibility of patient education materials should primarily focus on reducing the average complexity of words and shortening average sentence lengths.</p>","PeriodicalId":94317,"journal":{"name":"European heart journal. Imaging methods and practice","volume":"3 2","pages":"qyaf111"},"PeriodicalIF":0.0,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12448386/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145115857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}